Home › Funds › Millennium Management › RXRX
Millennium Management position in RXRX
RECURSION PHARMACEUTICALS IN · Health Care
Latest position (Q2 2026)1.83M sh
Reported value held$6.73M
Portfolio Weight0.00%
First reportedQ4 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2021 | 93.83K | $1.61M | New |
| Q1 2022 | 495.15K | $3.54M | Add |
| Q2 2022 | 383.17K | $3.12M | Reduce |
| Q3 2022 | 239.40K | $2.55M | Reduce |
| Q4 2022 | 695.37K | $5.36K | Add |
| Q1 2023 | 646.61K | $4.31K | Reduce |
| Q3 2023 | 658.36K | $5.04M | New |
| Q1 2024 | 52.38K | $522.20K | New |
| Q2 2024 | 100.00K | $750.00K | Add |
| Q3 2024 | 70.48K | $464.48K | Reduce |
| Q4 2024 | 28.31K | $191.38K | Reduce |
| Q1 2025 | 502.11K | $2.66M | Add |
| Q2 2025 | 739.41K | $3.74M | Add |
| Q4 2025 | 1.50M | $6.12M | New |
| Q1 2026 | 2.61M | $8.02M | Add |
| Q2 2026 | 1.83M | $6.73M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding RXRX
- Vanguard Group 47.19M sh · $193.00M · Q4 2025
- BlackRock Inc 50.30M sh · $184.62M · Q2 2026
- ARK Invest 41.34M sh · $151.71M · Q2 2026
- Baillie Gifford & Co 23.49M sh · $86.20M · Q2 2026
- Geode Capital Management 13.82M sh · $50.72M · Q2 2026
- UBS Group AG 8.95M sh · $32.84M · Q2 2026
- Norges Bank Investment Management 6.83M sh · $25.08M · Q2 2026
- Northern Trust Corp 4.76M sh · $17.46M · Q2 2026
- Marshall Wace 4.71M sh · $17.30M · Q2 2026
- Charles Schwab Investment Management 4.14M sh · $15.19M · Q2 2026
- Goldman Sachs Group 3.92M sh · $14.38M · Q2 2026
- Two Sigma Investments 3.35M sh · $12.31M · Q2 2026